BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 3, 2007
View Archived Issues
REVA Medical enrolls first patients in CAD study of bioresorbable stent
Read More
FDA approves YM BioSciences' IND for AeroLEF for severe pain
Read More
Advancis Pharmaceutical changes name to MiddleBrook Pharmaceuticals
Read More
Critical Therapeutics and Dey sign copromotion agreement for Perforomist
Read More
NicOx begins third pivotal phase III trail for osteoarthritis of the hip
Read More
Preliminary results of SBG for neuroblastoma indicate good safety profile
Read More
Preliminary results from two phase II trials of Xcytrin for lung cancer
Read More
CombinatoRx discontinues CRx-150 program for rheumatoid arthritis
Read More
Final ferumoxytol phase III results expected in summer
Read More
Gene Logic to discover new development paths for Lundbeck drug candidates
Read More
NovaDel Pharma focuses on programs nearing NDA submission
Read More
SkyePharma licenses SKP-1041 to Somnus Therapeutics
Read More
Encouraging interim blinded data from phase III SinuNase study
Read More
Treanda NDA filing planned for Q3
Read More
Promising data from arimoclomol open-label extension trial in ALS reported
Read More
Isotechnika completes enrollment for ISA-247 phase IIb kidney transplant trial
Read More
E1-I.N.T. yields sustained reductions in HbA1c levels in type 2 diabetes patients
Read More
Phase I study supports further clinical evaluation of eltrombopag
Read More
Administration of a 11beta-HSD1 inhibitor in the evening improves metabolic parameters in DIO mice
Read More
Diabetes snapshots: dipeptidyl peptidase IV inhibitors
Read More
Lipid-lowering and antidiabetic activity of DRL-17564, a novel selective PPARgamma modulator
Read More
New data on SGLT2 inhibitors sergliflozin, dapagliflozin available
Read More
Liraglutide effective in lowering HbA1c in Japanese type 2 diabetes patients
Read More
CTA-018 reduces blood levels of parathyroid hormone in phase I trial
Read More
Intercell and Novartis sign vaccine development partnership
Read More
Interim results for phase I study of ALX-0081
Read More
Novel agents for HIV infection reported in recent ViroChem, Pfizer and CNRS patents
Read More
New agents targeting hepatitis C described in recent patents
Read More
Novel analgesic agents imparted in recent patent literature
Read More
Sciele Pharma files sNDA to the FDA for new Sular formulation
Read More